Angela M.

Angela M. is a seasoned professional in the pharmaceutical and biotechnology sectors, currently serving as Nordic at MedChemExpress LLC since January 2023, where Angela has consistently achieved over a 60% monthly growth rate in the Nordic market. Prior experience includes roles at AstraZeneca, where Angela was involved in a breast cancer patient study and digital health solutions, and at Roche, leading pricing and access strategy for innovative biomedicines. Angela's background also encompasses project management at Novartis, business development at Eisai US, and management consulting at IMS Health. Angela holds a Master’s Degree in Bioentrepreneurship from Karolinska Institutet, a Bachelor's in Medicine from China Pharmaceutical University, and a Master’s Degree in Engineering Business Management from the University of Warwick.